Xtrem Biotech
-
DATABASE (56)
-
ARTICLES (44)
Rolf Schrömgens is best known as the CEO and co-founder of travel marketplace Trivago, where he has worked since 2006. The German entrepreneur is also a prolific early-stage investor.His most recent investments include participation in the €1.15m seed round of fintech StudentFinance and €8m Series A funding for German biotech innes.
Rolf Schrömgens is best known as the CEO and co-founder of travel marketplace Trivago, where he has worked since 2006. The German entrepreneur is also a prolific early-stage investor.His most recent investments include participation in the €1.15m seed round of fintech StudentFinance and €8m Series A funding for German biotech innes.
The Gassó family is a Spanish entreprenurial family known for its GAES auditive solutions and centers for the hearing-impaired, in existence since 1949. Though the family has many charitable interests, it had not disclosed any investments in tech startups until leading the 2019 seed round of biotech startup VEnvirotech, which produces bioplastics from corporates’ organic waste.
The Gassó family is a Spanish entreprenurial family known for its GAES auditive solutions and centers for the hearing-impaired, in existence since 1949. Though the family has many charitable interests, it had not disclosed any investments in tech startups until leading the 2019 seed round of biotech startup VEnvirotech, which produces bioplastics from corporates’ organic waste.
Co-founder of Uniplaces
University of Nottingham graduate Ben Grech holds a bachelor’s degree in Finance. Prior to co-founding Uniplaces in 2011, he was a biotech analyst at KBC Peel Hunt and a business analyst at SRC Oxford. He was also an associate at private equity firm HIG Capital for a year and founded NACUE, the UK’s leading membership organization for engaging students in enterprise. Grech is British and is also the founder of Nottingham Entrepreneurs in 2007 which he also presided over until 2009. He was CEO at Uniplaces until 2018 when he left the post and became Non-Executive Chairman.
University of Nottingham graduate Ben Grech holds a bachelor’s degree in Finance. Prior to co-founding Uniplaces in 2011, he was a biotech analyst at KBC Peel Hunt and a business analyst at SRC Oxford. He was also an associate at private equity firm HIG Capital for a year and founded NACUE, the UK’s leading membership organization for engaging students in enterprise. Grech is British and is also the founder of Nottingham Entrepreneurs in 2007 which he also presided over until 2009. He was CEO at Uniplaces until 2018 when he left the post and became Non-Executive Chairman.
Co-founder, CEO of Lluvia Sólida (Solid Rain)
Leonardo Rico Fernandez is CEO and co-founder of Mexican biotech startup Lluvia Sólida, a water retention solution for drought conditions, where he has worked since he re-founded it in 2017. He used the same name of a company he founded in 2012 and ran with a different team, which was dissolved in 2016. He is the son of the inventor of the technology, Sergio Rico Velasco, and was instrumental in positioning the product’s use from residual waste water treatment to agritech. Rico previously worked in a private school, Indo-American College, in Tlalnepantla in the State of Mexico City as a systems administrator. He graduated as an engineer in Electrical Systems from Monterrey University, Mexico City campus.
Leonardo Rico Fernandez is CEO and co-founder of Mexican biotech startup Lluvia Sólida, a water retention solution for drought conditions, where he has worked since he re-founded it in 2017. He used the same name of a company he founded in 2012 and ran with a different team, which was dissolved in 2016. He is the son of the inventor of the technology, Sergio Rico Velasco, and was instrumental in positioning the product’s use from residual waste water treatment to agritech. Rico previously worked in a private school, Indo-American College, in Tlalnepantla in the State of Mexico City as a systems administrator. He graduated as an engineer in Electrical Systems from Monterrey University, Mexico City campus.
Founded in 2008, KIZOO Technology Ventures is a seed and early-stage VC. Current CEO Michael Greve, who founded Flug.de and Web.de, has many years of experience in the German-speaking Internet industry. KIZOO generally focuses on SaaS, Internet and mobile startups, although it has recently ventured into rejuvenation biotech, investing in companies such as CellAge and LysoClear.
Founded in 2008, KIZOO Technology Ventures is a seed and early-stage VC. Current CEO Michael Greve, who founded Flug.de and Web.de, has many years of experience in the German-speaking Internet industry. KIZOO generally focuses on SaaS, Internet and mobile startups, although it has recently ventured into rejuvenation biotech, investing in companies such as CellAge and LysoClear.
Grupara Ventures focuses on helping startups in the healthcare, retail, foodtech, fintech, biotech and design sectors to transform into global brands. It also provides business and networking support to the startups, including mentoring, office space and access to other investors and potential customers. Grupara has also co-invested and worked with angel investors, such as Mari Elka Pangetsu, Andy Zain, Bunga Citra Lestari, Ashraf Sinclair and Justin Kan.
Grupara Ventures focuses on helping startups in the healthcare, retail, foodtech, fintech, biotech and design sectors to transform into global brands. It also provides business and networking support to the startups, including mentoring, office space and access to other investors and potential customers. Grupara has also co-invested and worked with angel investors, such as Mari Elka Pangetsu, Andy Zain, Bunga Citra Lestari, Ashraf Sinclair and Justin Kan.
Athos Capital is a venture capital firm established in 2017 with offices in Barcelona and Madrid. It currently operates a €1 million fund and has a portfolio of 10 Spain-based startups across the digital technology ecosystem (excluding real estate, biotech and healthcare). The team comprises Fernando Castiñeras, Robert Tomas, Giovanni Bologna and Elisabet Garriga, who have prior experience as venture capitalists, business consultants and entrepreneurs.
Athos Capital is a venture capital firm established in 2017 with offices in Barcelona and Madrid. It currently operates a €1 million fund and has a portfolio of 10 Spain-based startups across the digital technology ecosystem (excluding real estate, biotech and healthcare). The team comprises Fernando Castiñeras, Robert Tomas, Giovanni Bologna and Elisabet Garriga, who have prior experience as venture capitalists, business consultants and entrepreneurs.
Dayli Partners is a VC company in South Korea that specializes in biotech and healthcare investments. It is a partner of Korea's TIPS (Tech Incubator Program for Startups) initiative, which aims to find the best startups in the country and help them develop their potential. As of December 2019, it has an AUM total of $170.7m and aims to manage $350m in assets by the end of 2020.
Dayli Partners is a VC company in South Korea that specializes in biotech and healthcare investments. It is a partner of Korea's TIPS (Tech Incubator Program for Startups) initiative, which aims to find the best startups in the country and help them develop their potential. As of December 2019, it has an AUM total of $170.7m and aims to manage $350m in assets by the end of 2020.
CEO and co-founder of Beyond Leather Materials / Leap
German native Mikael Eydt graduated in economics in 2016 at Erlangen-Nürnberg’s Friedrich-Alexander University. He worked at his family’s hotel company in Germany while studying at university from 2011 to 2016. Eydt also briefly worked in sales for insurance company Debeka and completed his national service as a soldier in Germany. In 2017, Eydt went back to work as a junior manager at family-owned Hotel Eydt in Kirchheim.Currently based in Copenhagen, he is now the CEO and co-founder of Danish alt-leather biotech, Beyond Leather Materials, that produces vegan leather materials from apple waste. He was responsible for the startup’s business development for two years before becoming CEO in July 2020.
German native Mikael Eydt graduated in economics in 2016 at Erlangen-Nürnberg’s Friedrich-Alexander University. He worked at his family’s hotel company in Germany while studying at university from 2011 to 2016. Eydt also briefly worked in sales for insurance company Debeka and completed his national service as a soldier in Germany. In 2017, Eydt went back to work as a junior manager at family-owned Hotel Eydt in Kirchheim.Currently based in Copenhagen, he is now the CEO and co-founder of Danish alt-leather biotech, Beyond Leather Materials, that produces vegan leather materials from apple waste. He was responsible for the startup’s business development for two years before becoming CEO in July 2020.
Co-founder, CEO of SwissDeCode
Brij Sahi is CEO and co-founder at Swiss biotech SwissDeCode, which applies DNA testing to food traceability, He has worked there full-time since April 2016. Since 2011, Sahi has also been an adjunct professor at Webster University in Geneva, teaching Business Policy, Strategic Management and Leadership. He is also a Swiss-based private investor in unnamed companies.From 2000–2008, Sahi worked at airline IT and telecommunications company SITA in both Singapore and Switzerland, where he reached the role of VP working in sales and marketing. He previously worked for two-and-a-half years in the area of sales and marketing at GAMECO, an aircraft maintenance and services company in China. Sahi started his corporate career at British Airways, where he spent over 11 years in marketing and business development. Sahi holds an MBA from Cass Business School in London and a first degree in air transport engineering from City University, London.
Brij Sahi is CEO and co-founder at Swiss biotech SwissDeCode, which applies DNA testing to food traceability, He has worked there full-time since April 2016. Since 2011, Sahi has also been an adjunct professor at Webster University in Geneva, teaching Business Policy, Strategic Management and Leadership. He is also a Swiss-based private investor in unnamed companies.From 2000–2008, Sahi worked at airline IT and telecommunications company SITA in both Singapore and Switzerland, where he reached the role of VP working in sales and marketing. He previously worked for two-and-a-half years in the area of sales and marketing at GAMECO, an aircraft maintenance and services company in China. Sahi started his corporate career at British Airways, where he spent over 11 years in marketing and business development. Sahi holds an MBA from Cass Business School in London and a first degree in air transport engineering from City University, London.
PICC Capital Equity Investment Company
PICC Capital Equity Investment Company was founded in 2009 as a subsidiary of Chinese listed insurer PICC.In 2018, it set up a RMB 300m fund targeting health and elderly-care sectors. In 2020, the VC set up another fund to invest in cutting-edge technologies like biotech, integrated circuit, etc.
PICC Capital Equity Investment Company was founded in 2009 as a subsidiary of Chinese listed insurer PICC.In 2018, it set up a RMB 300m fund targeting health and elderly-care sectors. In 2020, the VC set up another fund to invest in cutting-edge technologies like biotech, integrated circuit, etc.
E²JDJ was founded in New Orleans in 2020 with an agtech and foodtech focus, including in the areas of cellular agriculture and synthetic biology. It has six startups in its portfolio and makes diverse investments. Its most recent disclosed investment was in the $4.7m July 2021 seed funding round of NovoNutrients, the US-based biotech producer of alt-protein from fermentation using CO2 and other emissions.
E²JDJ was founded in New Orleans in 2020 with an agtech and foodtech focus, including in the areas of cellular agriculture and synthetic biology. It has six startups in its portfolio and makes diverse investments. Its most recent disclosed investment was in the $4.7m July 2021 seed funding round of NovoNutrients, the US-based biotech producer of alt-protein from fermentation using CO2 and other emissions.
Bånt AB is the investment vehicle of Karl Sverker Forsén based in Luleå, a coastal city in Swedish Lapland. In May 2020, the Swedish family office invested in a Gothenburg startup Mycorena, a biotech that produces mycoproteins through fermentation. The fungi-based protein can be used as an alt-protein ingredient instead of traditional plant-based food components.
Bånt AB is the investment vehicle of Karl Sverker Forsén based in Luleå, a coastal city in Swedish Lapland. In May 2020, the Swedish family office invested in a Gothenburg startup Mycorena, a biotech that produces mycoproteins through fermentation. The fungi-based protein can be used as an alt-protein ingredient instead of traditional plant-based food components.
Co-founder, CTO of SwissDeCode
Gianpaolo Rando is CTO and co-founder at Swiss biotech SwissDeCode, which applies DNA testing to food traceability. He has worked there full-time since April 2016. Prior to this, Rando gained significant experience working in the field of genomics. He spent three years prior to SwissDeCode’s foundation trialing his DNA food testing technology in his startup BeerDeCoded and assisted in the launch of a compact DNA laboratory at Bento Bio in London. He previously spent almost three years at the University of Geneva in research, co-inventing a technology for ink to change color in response to a specific DNA sequence. His earlier position at the University of Lausanne as a post-doctoral fellow in genomics saw him lead a nine-man team for three and a half years, discovering the hormone that prepares newborns to lactate. Rando’s first post was at Trangenic Operative Products, leading animal research there. Italian-born Rando holds a PhD in biotechnology and pharmacology from the University of Milan as well as a qualification in data science.
Gianpaolo Rando is CTO and co-founder at Swiss biotech SwissDeCode, which applies DNA testing to food traceability. He has worked there full-time since April 2016. Prior to this, Rando gained significant experience working in the field of genomics. He spent three years prior to SwissDeCode’s foundation trialing his DNA food testing technology in his startup BeerDeCoded and assisted in the launch of a compact DNA laboratory at Bento Bio in London. He previously spent almost three years at the University of Geneva in research, co-inventing a technology for ink to change color in response to a specific DNA sequence. His earlier position at the University of Lausanne as a post-doctoral fellow in genomics saw him lead a nine-man team for three and a half years, discovering the hormone that prepares newborns to lactate. Rando’s first post was at Trangenic Operative Products, leading animal research there. Italian-born Rando holds a PhD in biotechnology and pharmacology from the University of Milan as well as a qualification in data science.
COO and co-founder of Because Animals
Joshua Errett graduated in philosophy in 2004 and completed a postgraduate degree in journalism in 2006. He also completed an MBA in entrepreneurial and small business operations in Indiana University in 2015.In 2004, he co-founded Torontoist.com, a media website that attracted thousands of views per day. He left the startup to join New Brunswick Telegraph Journal as a reporter for one year before becoming digital managing editor for NOW magazine. In 2013, he went on to work for three years as a senior producer at the Canadian Broadcasting Corporation (CBC).He met Shannon Falconer at a cat rescue project in Toronto. The two pet owners co-founded the biotech Because Animals in 2016 to create more sustainable food for dogs and cats. Errett worked as a marketing manager at Equitable (EQ) Bank before working full-time as COO at Because Animals.
Joshua Errett graduated in philosophy in 2004 and completed a postgraduate degree in journalism in 2006. He also completed an MBA in entrepreneurial and small business operations in Indiana University in 2015.In 2004, he co-founded Torontoist.com, a media website that attracted thousands of views per day. He left the startup to join New Brunswick Telegraph Journal as a reporter for one year before becoming digital managing editor for NOW magazine. In 2013, he went on to work for three years as a senior producer at the Canadian Broadcasting Corporation (CBC).He met Shannon Falconer at a cat rescue project in Toronto. The two pet owners co-founded the biotech Because Animals in 2016 to create more sustainable food for dogs and cats. Errett worked as a marketing manager at Equitable (EQ) Bank before working full-time as COO at Because Animals.
Xtrem Biotech, an agritech startup from Granada, seeks global expansion
With its research roots in the University of Granada, Xtrem Biotech was named one of the world's most innovative agtech spin-offs by accelerator TERRA Food & AgTech
Daniel Oliver: Building a "Facebook" for investments in biotech startups
The biologist and crowdfunding expert has pioneered the growth of Spanish biotech startups, providing access to early-stage investments, with support from scientific experts worldwide
Meatable: Cell-based meat startup secures $47m Series A for scalable technology
The Dutch startup offers a pioneering technology for quickly scaling cell-based meat production while eliminating the need for animal-derived growth media
Forget solar panels and batteries, Bioo wants to scale soil bioelectricity generation
Improving on NASA’s microbial fuel cell tech, Bioo hopes to boost crop efficiency and transform the way urbanites live, in future green cities powered by plants
TurtleTree Labs: Creating sustainable mammalian milk alternatives from stem cells
Founder’s search for high-quality dairy milk led to the creation in a lab of naturally occurring ingredients found in human milk for supply to dairy milk and infant formula businesses
Sequoia Capital China holds steady with investments in healthcare, biotech and green economy
China’s most active investor increases bets on sectors beyond the consumer internet and edtech recently hurt by regulatory clampdown
Because Animals: Pioneering cultured meat for pets
The biotech startup is disrupting the pet food processing industry with cell-based food to minimize environmental “pawprints” and promote animal welfare
NovoNutrients: Tackling the dual problems of CO2 emissions and over-fishing
The first to transform CO2 to fish food, NovoNutrients is trialing with industry giants Skretting and Chevron, and will soon raise Series A funding
Poliloop: Tackling pollution crisis with plastic-eating bacteria for industrial use
Hungarian biotech Poliloop is closing $2m seed funding for “bacteria cocktail” that breaks down plastic into organic waste quickly, enabling more affordable and eco-friendly waste management
Qorium: Lab-grown premium leather for the future of luxury
The Dutch biotech startup co-founded by cell-based meat pioneer Mark Post is targeting the luxury goods market with its “clean leather” sheets made from cultivating bovine skin cells, and plans to raise up to €100m
Mycorena: Fungi-based vegan protein challenging traditional plant-based ingredients
Award-winning Swedish biotech startup is scaling production of mycoprotein to become a key player in the emerging market for functional proteins
TreeFrog Therapeutics: Mimicking how stem cells grow in the human body
The French biotech’s proprietory technology to cultivate pluripotent stem cells in a 3D environment can be scaled to mass-produce high-quality cells to treat diseases such as Parkinson’s
New Food Invest: Opportunities in the European alt-protein space
With a record €2.4bn investment in 2019, Europe’s foodtech sector appears poised for continued growth, but startups, corporations, governments and even universities can do more, experts say
Future Food Asia by ID Capital: Introducing Asia's agrifood startups to the world
More than a meeting of startups and investors, the conference showcases ID Capital’s investment thesis and Big Ag’s support for agrifood tech in the world’s most populous region
Cubiq Foods: Bioreactor farms producing the food of tomorrow
Growing appetite for meat alternatives expected to fuel demand for Cubiq’s low calorie, Omega 3-enriched lab-grown fats
Sorry, we couldn’t find any matches for“Xtrem Biotech”.
POPULAR DATABASE
